Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy

Cancer

Volumn 106, Issue 11, 2006, Pages 2369-2375

  Secin, Fernando P ^a   Bianco Jr , Fernando J ^a   Vickers, Andrew J ^a   Reuter, Victor ^a   Wheeler, Thomas ^b   Fearn, Paul A ^a   Eastham, James A ^a   Scardino, Peter T ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer; Outcomes; Prostatectomy; Prostatic neoplasms; Seminal vesicle invasion; Surgery; Survival

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RISK FACTOR; SEMINAL VESICLE DISEASE; SURGICAL TECHNIQUE;

AGED; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SEMINAL VESICLES; SURVIVAL RATE;

EID: 33646865689     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.21895     Document Type: Article

References (21)

1. Salomon L, Anastasiadis AG, J̇ohnson CW, et al. Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression. Urology. 2003;62:304-309.
2. van den Ouden D, Hop WC, Kranse R, Schroder FH. Tumour control according to pathological variables in patients treated by radical prostatectomy for clinically localized carcinoma of the prostate. Br J Urol. 1997;79:203-211.
3. Moul JW, Wu H, Sun L, et al. Epidemiology of radical prostatectomy for localized prostate cancer in the era of prostate-specific antigen: an overview of the Department of Defense Center for Prostate Disease Research national database. Surgery. 2002;132:213-219.
4. Jewett HJ, Eggleston JC, Yawn DH. Radical prostatectomy in the management of carcinoma of the prostate: probable causes of some therapeutic failures. J Urol. 1972;107:1034-1040.
5. Bloom KD, Richie JP, Schultz D, Renshaw A, Saegaert T, D'Amico AV. Invasion of seminal vesicles by adenocarcinoma of the prostate: PSA outcome determined by preoperative and postoperative factors. Urology. 2004;63:333-336.
6. Blute ML, Bergstralh EJ, Iocca A, Scherer B, Zincke H. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy. J Urol. 2001;165:119-125.
7. Debras B, Guillonneau B, Bougaran J, Chambon E, Vallancien G. Prognostic significance of seminal vesicle invasion on the radical prostatectomy specimen. Rationale for seminal vesicle biopsies. Eur Urol. 1998;33:271-277.
8. Epstein JI, Carmichael M, Walsh PC. Adenocarcinoma of the prostate invading the seminal vesicle: definition and relation of tumor volume, grade and margins of resection to prognosis. J Urol. 1993;149:1040-1045.
9. Epstein JI, Partin AW, Potter SR, Walsh PC. Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters. Urology. 2000;56:283-288.
10. Ohori M, Scardino PT, Lapin SL, Seale-Hawkins C, Link J, Wheeler TM. The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer. Am J Surg Pathol. 1993;17:1252-1261.
11. Sofer M, Savoie M, Kim SS, Civantos F, Soloway MS. Biochemical and pathological predictors of the recurrence of prostatic adenocarcinoma with seminal vesicle invasion. J Urol. 2003;169:153-156.
12. Tefilli MV, Gheiler EL, Tiguert R, et al. Prognostic indicators in patients with seminal vesicle involvement following radical prostatectomy for clinically localized prostate cancer. J Urol. 1998;160(3 Pt 1):802-806.
13. Lee HM, Solan MJ, Lupinacci P, Gomella LG, Valicenti RK. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy. Urology. 2004;64:84-89.
14. Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium. Urology. 2001;58:843-848.
15. Ohori M, Scardino PT. Localized prostate cancer. Curr Probl Surg. 2002;39:833-957.
16. Elder JS, Jewett HJ, Walsh PC. Radical perineal prostatectomy for clinical Stage B2 carcinoma of the prostate. J Urol. 1982;127:704-706.
17. Flocks RH. The treatment of Stage C prostatic cancer with special reference to combined surgical and radiation therapy. J Urol. 1973;109:461-463.
18. Flocks RH, O'Donoghue EP, Millerman LA, Culp DA. Management of Stage C prostatic carcinoma. Urol Clin North Am. 1975;2:163-179.
19. Koh H, Kattan MW, Scardino PT, et al. A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results. J Urol. 2003;170(4 Pt 1):1203-1208.
20. Theodorescu D, Frierson JHF. When is a negative lymph node really negative? Molecular tools for the detection of lymph node metastasis from urological cancer. Urol Oncol. 2004;22:256-259.
21. Freedland SJ, Aronson WJ, Presti JC Jr., et al. Predictors of prostate-specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomy. Cancer. 2004;100:1633-1638.